Dry Eye Syndrome - US Drug Forecast and Market Trends, Size, Shares, Analysis, Opportunities to 2024
Dry Eye Syndrome - US Drug Forecast and Market Analysis to 2024
Summary
Dry Eye Syndrome (DES), also known as keratoconjunctivitis sicca, is a multifactorial disease of the tears and ocular surface. This ocular condition can cause ocular discomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. The DES market has had few new therapeutics in the last decade with Japan seeing the most change in this time with the arrival of Diquas and Mucosta in 2010 and 2013, respectively. However, the lack of treatment options is about to change with the expected launch of numerous pipeline DES drugs during the forecast period, which will be a significant driver of growth in the 9MM. Indeed, this change has already been initiated with Ikervis recent arrival in Europe in 2015. Furthermore, additional marketing approvals are being sought for currently marketed DES drugs, Restasis and Diquas, in new countries in the 9MM, which will provide a source of growth in this market.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=785529
GlobalData estimates that DES drug sales in the US reached $1.3 billion during 2014, making it the largest market within the 9MM. After an initial period of minimal growth, GlobalData estimates that the DES market will undergo a period of steady growth from 2016 and beyond, but this growth will begin to wane slightly towards the end of the forecast period. This growth is mainly attributed to the expected introduction of the highly anticipated pipeline DES drug, lifitegrast in late 2016, and additional pipeline products in 2018. This expansion of treatment options for DES patients will have the added effect of increasing overall treatment rates in the US.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Related Reports 9
3 Disease Overview 11
3.1 Etiology and Pathophysiology 11
3.1.1 Etiology 11
3.1.2 Pathophysiology 14
3.2 Disease Classification 16
3.3 Symptoms 17
3.4 Prognosis 20
3.5 Quality of Life 21
4 Disease Management 22
4.1 Diagnosis and Treatment Overview 22
4.1.1 Diagnosis 22
4.1.2 Treatment Guidelines 25
4.1.3 Clinical Practice 26
4.2 US 32
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://deep-research-report.blogspot.com/